Special Issue "Antibiotics and Urinary Tract Infections"
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: closed (10 January 2014)
Dr. Kurt G. Naber
Technical University of Munich, Munich, Germany
Phone: +49 9421 33369
Interests: urogenital infections; clinical studies; microbiology of uropathogens; PK/PD of antimicrobials; treatment of UTI; prostatitis
Professor Truls E. E. Bjerklund Bjerklund Johansen
Department of Urology, Oslo University Hospital, 0424 Oslo, Norway
Interests: community and hospital acquired urinary tract infections; urosepsis; complications after prostate biopsies; focal treatment of prostate cancer
Urinary tract infections (UTI) are one of the most frequently occurring infections, not only community acquired, but also hospital acquired infections. An increase of resistant uropathogens against commonly used antibiotics can be observed worldwide, a subject of great concern.
Several strategies are discussed how to cope with this problem:
i) not to use antibiotics, when not indicated, e.g. asymptomatic bacteriuria, or when non-antimicrobial measures are available, e.g. for prophylaxis of recurrent UTI;
ii) to prefer even old antibiotics, which still have preserved their antibacterial activity against uropathogens;
iii) if broad spectrum antibiotics are needed for empiric therapy of severe infections, to use the right and high enough dosages to reduce selection of resistant pathogens, and to step down to a more tailored antibiotic therapy as soon as possible;
iv) to control and try to avoid health care associated UTI by optimal hygienic and interventional strategies; and last but not least
v) to stimulate development of new antibiotics, especially when new bacterial targets can be approached
"Antibiotics" will publish a special issue focusing on prevention, treatment and controlling UTI in the community, but also in health care institutions. It is our pleasure to invite submissions of high quality research based papers related to the topics mentioned above.
Dr. Kurt G. Naber
Dr. Truls E. Bjerklund Johansen
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed Open Access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 300 CHF (Swiss Francs). English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.
- epidemiology, classification and risk factors of urinary tract infections (UTI)
- diagnostics, treatment and prevention of UTI
- antibiotic resistance of uropathogens
- suitable old and new antibiotics for treatment of UTI
- non-antimicrobial management of UTI